Cheerland Biotechnology: Digitalizing operations in the cloud for more business agility
Explore Cheerland Biotechnology’s journey with SAP
When China-based Cheerland Biotechnology Investment Co. Ltd. sought an advanced digital technology backbone with comprehensive business functionality, it found the best fit by investing in RISE with SAP S/4HANA Cloud, private edition. The solution now forms the cornerstone of its unified business and bioscience factory operations.
| Industry | Region | Company Size | Partner |
| Life sciences | Guangdong, China | >1,000 employees | Shenzhen JianGuang Digital Technology (JGDT) |
improved supply chain efficiency.
fewer current good manufacturing practices tickets.
reduction in IT hardware costs.
Head of IT, Cheerland Biotechnology Investment Co. Ltd.
| Industry | Region | Company Size | Partner |
| Life sciences | Guangdong, China | >1,000 employees | Shenzhen JianGuang Digital Technology (JGDT) |
improved supply chain efficiency.
fewer current good manufacturing practices tickets.
reduction in IT hardware costs.
Head of IT, Cheerland Biotechnology Investment Co. Ltd.
Actively embracing digital transformation to stay ahead
Cheerland Biotechnology is committed to making biomedicine affordable and accessible worldwide. Engaged in molecular diagnostics, biologics contract development and manufacturing, and the provision of clinical services, the company aspires to be recognized as a leading biotech enterprise in China and globally. The company was selected into the Xinhua News Agency’s National Brands Project in 2021.
Led by an international team with extensive experience in biologics manufacturing, Cheerland Biotechnology provides large-scale manufacturing services to the global biotech industry. This includes offering the first 15-kiloliter bioreactor in China, robust process design, and compliance with global regulations.
Conducting the majority of its business overseas, the time was right for Cheerland Biotechnology to streamline compliance with the current good manufacturing practices (cGMP) quality standards regulated by the World Health Organization (WHO). It also had to meet the European Union’s data privacy regulations. To achieve these aims, the company needed to modernize its operations on a digital foundation, unify data and processes across the four businesses, and enable data-driven decision-making. As a first step, Cheerland Biotechnology sought a scalable and future-ready technology foundation to unify its business operations and support the integration of other SAP solutions in due course.
Head of IT, Cheerland Biotechnology Investment Co. Ltd.
Practicing lean management with data-driven decision-making
Impressed by SAP’s global reputation and the wide use of SAP S/4HANA Cloud by biosciences companies in China and throughout the world, Cheerland Biotechnology invested in RISE with SAP S/4HANA Cloud, private edition. The solution offers AI, machine learning, robotic process automation, and support for integrated finance, supply chain, manufacturing, and sales and distribution processes. It allows for tightly integrated business operations by removing internal barriers and enables data-driven decision-making through access to rich data and analytics, enhancing the biotech company’s corporate management capabilities.
The private edition of SAP S/4HANA Cloud also accelerates time to value, provides embedded support for best practices and processes, and delivers a scalable and future-ready digital foundation. Applying rigid data protection and security practices, it allows the company to confidently meet the provisions of the stringent regulations set down by the European Union’s data protection legislation and WHO’s cGMP.
To help it implement the solution, Cheerland Biotechnology joined forces with experienced SAP partner Shenzhen JianGuang Digital Technology (JGDT). With more than two decades of collaborating with SAP and proven experience in the bioscience field, JGDT’s seasoned consultants extended the internal team’s capabilities, helping mitigate implementation risk and cost.
Head of IT, Cheerland Biotechnology Investment Co. Ltd.
Increasing operational efficiency in large-scale drug production
SAP S/4HANA Cloud, private edition now provides Cheerland Biotechnology with a highly reliable and future-ready business backbone to support digitalized operations. The company successfully unified data from the business units of its four main businesses and streamlined front-end and back-end processes, gaining enterprise-wide visibility.
With tightly integrated business and finance processes, the company has seen a 30% increase in supply chain efficiency, while it’s shaved three days off the time required for month-end closing activities. By adopting standardized business processes and embedded functionality, Cheerland Biotechnology is now managing the drug manufacturing business in line with global best practices. And thanks to rigid data protection and security practices, the company has halved the number of cGMP tickets it needs to resolve.
In addition, the company standardized its cost control practices for contract development and manufacturing using a milestone management approach, allowing it to align forward planning and cost control processes with orders.
Investment in RISE with SAP S/4HANA Cloud, private edition also helped the company reduce the cost of its IT hardware requirements by 25%.
Featured partner
Shenzhen JianGuang Digital Technology (JGDT) is a leading provider of IT solutions and outsourcing services in China. Focused on supporting digital transformation in traditional industries, its core offerings are centered on implementing business software, including ERP, supply chain management, customer relationship management, and master data management applications, and providing related services.